Article thumbnail

MicroRNA Role in Thyroid Cancer Development

By Francesca Marini, Ettore Luzi and Maria Luisa Brandi

Abstract

MicroRNAs (miRNAs) are endogenous noncoding RNAs that negatively regulate gene expression by binding the 3′ noncoding region of the messenger RNA targets inducing their cleavage or blocking the protein translation. They play important roles in multiple biological and metabolic processes, including developmental timing, signal transduction, and cell maintenance and differentiation. Their deregulation can predispose to diseases and cancer. miRNA expression has been demonstrated to be deregulated in many types of human tumors, including thyroid cancers, and could be responsible for tumor initiation and progression. In this paper we reviewed the available data on miRNA deregulation in different thyroid tumors and describe the putative role of miRNA in thyroid cancer development

Topics: Review Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier: oai:pubmedcentral.nih.gov:3112511
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2007). 20 years of RET/PTC in thyroid cancer: clinico-pathological correlations,”
  2. (2001). A cellular function for the RNAinterference enzyme dicer in the maturation of the let-7 small temporal
  3. (2006). A limited set of human MicroRNA is deregulated in follicularthyroidcarcinoma,”JournalofClinicalEndocrinology and Metabolism,
  4. (2002). A microRNA in a multipleturnover RNAi enzyme complex,”
  5. (2005). A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia,” The New England
  6. (2003). A r g r a v e s
  7. (2001). Activin A and activin receptors in thyroid cancer,”
  8. (2005). C h a n ,A .M .K r i c h e v s k y ,a n dK .S .K o s i k ,“ M i c r o
  9. (2005). C i a f r `
  10. (2010). Cancer: microRNA expression provides clues about the aggressiveness of papillary thyroid carcinoma,”
  11. Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers,” Medicinal Research Reviews.
  12. Cleavage of Scarecrow-like mRNA targets directed by a class of
  13. (2006). Correlation between genetic alterations and microscopic features, clinical manifestations, and prognostic characteristics of thyroid papillary12
  14. (2009). Decreased expression of miR-125b and miR100 in oral cancer cells contributes to malignancy,”
  15. (1993). Di Renzo et al., “Expression of the c-Met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression,”
  16. (2010). Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas,”
  17. (2008). Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines,” Cancer Science,v o l .9 9 ,n o .2 ,p p .
  18. (2006). Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model,”
  19. (2009). Effects of let7 microRNA on cell growth and differentiation of papillary thyroid cancer,”
  20. (2000). erren,L.P .W engetal.,“Differentialnuclearand cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors,”
  21. Exportin5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs,”
  22. (1993). Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues,”
  23. (2004). G.A.Calin,C.G.Liu,C.Sevignanietal.,“MicroRNAprofiling reveals distinct signatures in B cell chronic lymphocytic leukemias,”
  24. (2005). H.He,K.Jazdzewski,W.Lietal.,“TheroleofmicroRNAgenes in papillary thyroid carcinoma,”
  25. (2001). Human fibulin-4: analysis of its biosynthetic processing and mRNA expression in normal and tumour tissues,”
  26. (2004). Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,”
  27. (2009). Identification of novel microRNA targets based on microRNA signatures in bladder cancer,”
  28. (2005). L e w i s ,C .B .B u r g e ,a n dD .P .B a r t e l ,“ C o n s e r v e ds e e d pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,”
  29. (2009). Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs
  30. (2010). Mammalian microRNAs: experimental evaluation of novel and previously annotated genes,”
  31. (2008). MicroRNA analysis as a potential diagnostic tool for papillary thyroid carcinoma,”
  32. (2006). MicroRNA deregulation in human thyroid papillary carcinomas,”
  33. (2005). MicroRNA expression profilesclassifyhumancancers,”Nature,vol.435,no.7043,pp. 834–838,
  34. (2005). MicroRNA gene expression deregulation in human breast cancer,”
  35. (2008). MicroRNA-10a binds the 5 UTR of ribosomal protein mRNAs and enhances their translation,”
  36. (2010). MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2,” Hepatology,
  37. (2006). MicroRNA-cancer connection: the beginning of a new tale,”
  38. (2004). MicroRNA-directed cleavage of HOXB8
  39. (2007). MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27 protein levels and cell cycle,”
  40. (2010). MiR-125b is critical for the suppression of human U251 glioma stem cell proliferation,”
  41. (2010). MiR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF mutation,”
  42. (2008). MYC stimulates EZH2 expression by repression of its negative regulator
  43. (2008). N i k i f o r o v a ,G .C .T s e n g ,D .S t e w a r d ,D .D i o r i o ,a n d
  44. (2009). N i k i f o r o v a ,S .I .C h i o s e a ,a n dY .E .N i k i f o r o v , “MicroRNA expression profiles in thyroid tumors,”
  45. (2008). Oncogenic role of miR-17-92 cluster in anaplastic thyroid cancer cells,”
  46. (2008). P a r k ,A .B .G a u r ,E .L e n g y e l ,a n dM .E .P e t e r ,“ T h em i R -200 family determines the epithelial phenotype of cancer cells by targetingtheE-cadherin repressorsZEB1andZEB2,”Genes and Development,
  47. (1992). Progression of human cutaneous melanoma is associated with loss of expression of c-kit protooncogene receptor,”
  48. (2000). PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells ismediatedbyp27(kip1),”Oncogene,vol.19,no.28,pp.3146– 3155,
  49. (2005). R.A.Dickins,M.T.Hemann,J.T.Zilfouetal.,“Probingtumor phenotypes using stable and regulated synthetic microRNA precursors,”
  50. (2007). R.Visone,P.Pallante,A.Vecchioneetal.,“SpecificmicroRNAs are downregulated in human thyroid anaplastic carcinomas,”
  51. (2003). Reduced accumulation of specific MicroRNAs in colorectal neoplasia,”
  52. (2010). Regulation of mRNA translation and stability by microRNAs,”
  53. (2007). S.Vasudevan,Y.Tong,andJ.A.Steitz,“Switchingfromrepression to activation: microRNAs can up-regulate translation,”
  54. (2003). Sequence requirements for micro RNA processing and function in human cells,”
  55. (2005). Silencing of microRNAs in vivo with ‘antagomirs’,”
  56. (2002). Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer,”
  57. (2005). siRNA and miRNA: an insight into RISCs,” Trends in
  58. (2004). Specificity of microRNA target selection in translational repression,”
  59. (2005). Telomerase activity in thyroid neoplasms evaluated by the expression of human telomerase reverse transcriptase (hTERT),”
  60. (2007). Tetzlaff,A .L i u ,X .X ue ta l . ,“ D i fferential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffine m b e d d e d tissues,”
  61. (1999). The biology of stem cell factor and its receptor C-kit,”
  62. (1995). Transformation of thyroid epithelium is associated with loss of c-kit receptor,”
  63. (2009). X.Zhang,I.Neganova,S.Przyborskietal.,“AroleforNANOG in G1 to S transition in human embryonic stem cells through direct binding of CDK6 and CDC25A,”
  64. (2004). Yanagisawa et al., “Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival,”